Schneider FS, Starling MC, Duarte CG, Machado de Avila R, Kalapothakis E, Silva Suarez W, Tintaya B, Flores Garrido K, Seraylan Ormachea S, Yarleque A, Bonilla C, Chávez-Olórtegui C. Preclinical testing of Peruvian anti-bothropic anti-venom against Bothrops andianus snake venom.
Toxicon 2012;
60:1018-21. [PMID:
22796381 DOI:
10.1016/j.toxicon.2012.06.018]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Revised: 06/20/2012] [Accepted: 06/28/2012] [Indexed: 12/01/2022]
Abstract
Bothrops andianus is a venomous snake found in the area of Machu Picchu (Peru). Its venom is not included in the antigenic pool used for production of the Peruvian anti-bothropic anti-venom. B. andianus venom can elicit many biological effects such as hemorrhage, hemolysis, proteolytic activity and lethality. The Peruvian anti-bothropic anti-venom displays consistent cross-reactivity with B. andianus venom, by ELISA and Western Blotting and is also effective in neutralizing the venom's toxic activities.
Collapse